REL and neoplasm: The CD11b+Gr-1+ cells in tumor, tdLN, spleen and blood of the NPc-Rel-treated tumor-bearing mice stayed comparable to PBS and NPempty groups (Supplementary Figures 6D, I, Supplementary Figures 7C, E, F).